{
  "id": 3807378,
  "title": "FDA approves Moderna’s updated COVID-19 vaccines for 2026-2027",
  "url": "https://urgent.news/2026/08/27/fda-approves-modernas-updated-covid-19-vaccines-for-2026-2027",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T20:04:36.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/fda-approves-modernas-updated-covid19-vaccines-for-20262027-93CH-4880084"
  },
  "original_language": "en",
  "account": null,
  "summary": "The U.S. Food and Drug Administration (FDA) has approved Moderna's updated COVID-19 vaccines, Spikevax and mNEXSPIKE, for the 2026-2027 season, according to a press release from the company. These updated vaccines contain the JN.1-lineage XFG subvariant of SARS-CoV-2, as recommended by the FDA. The 2026-2027 formula for Spikevax has received approval in several countries, including Europe, South Korea, Singapore, Switzerland, and the United Kingdom. The 2026-2027 formula for mNEXSPIKE has been approved by regulators in Japan. Additional regulatory applications are under review globally. Moderna CEO Stéphane Bancel emphasized that COVID-19 remains a serious public health threat, responsible for numerous outpatient visits and hospitalizations in the U.S. last year alone. The updated vaccines are expected to be available in the coming days.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Seeking Alpha News",
        "title": "Pfizer, BioNTech win approval for updated COVID-19 shot",
        "url": "https://urgent.news/2026/08/27/pfizer-biontech-win-approval-for-updated-covid-19-shot",
        "published": "2026-08-27T21:16:19.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}